Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(537)
•••
Comment by riverrrowon Oct 03, 2020 8:57am
94 Views
Post# 31662685

RE:RE:RE:RE:RE:RE:RE:HCQ ....ANYONE ??????

RE:RE:RE:RE:RE:RE:RE:HCQ ....ANYONE ??????It's estimated that 40% of Americans and Canadians are deficient in Vit. D with the lower normal limit being 25 ng/ml, well below the 40 ng/ml which has been shown to be very effective. Some Vit. D advocates suggest a much higher blood level of Vit. D of 60ng/ml. The recommended daily allowance of Vit. D in many countries ranges from 600 to 2000 iu .Interestingly, rumour has it that Dr. Fauci, senior adviser to the President, reported in an email that he takes 6000 iu per day although this may have been a typo and he may just be taking 600 iu per day. A significant difference. Too bad he hasn't clarified this. GLTA.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities